TY - JOUR
T1 - Community-acquired Pneumonia and Acute Respiratory Distress Syndrome
T2 - Prevalence, Risk, and Prognosis
AU - Cillóniz, Catia
AU - Nicolini, Antonello
AU - Luque, Nestor
AU - Torres, Antoni
N1 - Publisher Copyright:
© 2018 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2018
Y1 - 2018
N2 - Severe community-acquired pneumonia is the most common cause of acute respiratory distress syndrome (ARDS). Despite multiple improvements in the last 10 years, this syndrome remains highly prevalent worldwide and is associated with high mortality and long-term morbidity rates. Several factors are related to the increasing risk of ARDS. Clinicians should be familiar with the use of lung-protective strategies and the mechanism of ventilator-induced lung injury, as ventilator management of ARDS is complex. Clinical trials are now needed, to investigate adjunctive therapies in patients with severe pneumonia and ARDS, such as systemic corticosteroids.
AB - Severe community-acquired pneumonia is the most common cause of acute respiratory distress syndrome (ARDS). Despite multiple improvements in the last 10 years, this syndrome remains highly prevalent worldwide and is associated with high mortality and long-term morbidity rates. Several factors are related to the increasing risk of ARDS. Clinicians should be familiar with the use of lung-protective strategies and the mechanism of ventilator-induced lung injury, as ventilator management of ARDS is complex. Clinical trials are now needed, to investigate adjunctive therapies in patients with severe pneumonia and ARDS, such as systemic corticosteroids.
KW - acute respiratory distress syndrome
KW - communityacquired pneumonia
KW - pneumonia
UR - http://www.scopus.com/inward/record.url?scp=85046870434&partnerID=8YFLogxK
U2 - 10.1097/CPM.0000000000000262
DO - 10.1097/CPM.0000000000000262
M3 - Article
AN - SCOPUS:85046870434
SN - 1068-0640
VL - 25
SP - 100
EP - 106
JO - Clinical Pulmonary Medicine
JF - Clinical Pulmonary Medicine
IS - 3
ER -